Prognosis
Pfizer Covid Vaccine Faces Hurdles After FDA Filing Friday
- Information on Pfizer’s shot is now in regulators’ hands
- FDA advisers to meet in early December to discuss trial data
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
Pfizer Inc. and BioNTech SE requested emergency authorization of their Covid vaccine on Friday, and it could take at least three weeks for a U.S. Food and Drug Administration decision as trial data is probed by agency staff and outside advisers.